Bayer sees FY25 core EPS EUR 4.50-EUR 5.00 on currency-adjusted basis

The company said, “On a currency-adjusted basis, Bayer (BAYRY) expects to generate sales of 45 billion to 47 billion euros in 2025. This corresponds to a change of minus 3 to plus 1 percent on a currency- and portfolio-adjusted basis. On a currency-adjusted basis, the company anticipates EBITDA before special items of 9.5 billion to 10.0 billion euros, core earnings per share of 4.50 to 5.00 euros, and free cash flow of 1.5 billion to 2.5 billion euros. Net financial debt as of year-end 2025 is expected to amount to 31.0 billion to 32.0 billion euros on a currency-adjusted basis. Bayer has also prepared its guidance based on the closing exchange rates as of December 31, 2024, and the differences to the currency-adjusted forecast above are as follows: At Group level, it expects to post EBITDA before special items of 9.3 billion to 9.8 billion euros, core earnings per share of 4.25 to 4.75 euros, free cash flow of 1.3 billion to 2.3 billion euros, and net financial debt of 31.2 billion to 32.2 billion as of year-end 2025.”